ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

tert-Butyl ((1R,3S)-3-carbamoylcyclohexyl)carbamate → tert-butyl N-[(1R,3S)-3-[[5-fluoro-4-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl]carbamate

HRID 598
印刷

反応式

HRID 598 の反応式
CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(N)=O)C1.Fc1cnc(Cl)cc1-c1cnn2c1CCCC2>C1COCCO1.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1>CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(F)cn2)C1
参加物反応条件実験手順出典と根拠反応ノート

参加物

7

反応物 2

HCID 71279992tert-Butyl ((1R,3S)-3-carbamoylcyclohexyl)carbamateHCID 1241553343-(2-Chloro-5-fluoro-4-pyridinyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine

生成物 1

HCID 124164056tert-butyl N-[(1R,3S)-3-[[5-fluoro-4-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl]carbamate収率 37.41%

試薬・触媒・溶媒 4

HCID 10796Cesium carbonate試薬
HCID 636044
1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)
触媒
HCID 11979704Tetrakis(triphenylphosphine)palladium触媒
HCID 312751,4-Dioxane溶媒

反応条件

温度
120 °C

実験手順

Tetrakis(triphenylphosphine)palladium(0) (0.092 g, 0.08 mmol) was added to 3-(2-chloro-5-fluoropyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine (0.200 g, 0.79 mmol), tert-butyl ((1R,3S)-3-carbamoylcyclohexyl)carbamate (0.231 g, 0.95 mmol) and 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (0.092 g, 0.16 mmol) and Cesium carbonate (0.777 g, 2.38 mmol) in 1,4-dioxane (5.98 ml). Degassed for 5 mins under nitrogen and the resulting suspension was stirred at 120 °C for 2 hours in the microwave reactor. The reaction mixture was partitioned between water (20ml) and DCM (40ml) and separated using a phase separation cartridge. The organics were absorbed onto silica and purified by flash silica chromatography, elution gradient 0 to 60% EtOAc in heptane. Still impure but telescoped through to next stage without further purification. (136mg).

出典と根拠

ORDレコード
ord-c9fc8ca9766b49dfbbd86d67f996e21e
出典データセット
750 AstraZeneca ELN dataset
元リンク
出典を表示

反応ノート

このページの内容参加物反応条件実験手順出典と根拠反応ノート